UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

High-throughput platelet spreading analysis: a tool for the diagnosis of platelet-based bleeding disorders

Haematologica (Roma), 2020-03, Vol.105 (3), p.e124

2020

Volltextzugriff (PDF)

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Blood advances, 2017-06, Vol.1 (15), p.1159-1166

2017

Volltextzugriff (PDF)

Investigation of the contribution of an underlying platelet defect in women with unexplained heavy menstrual bleeding

Platelets (Edinburgh), 2019-01, Vol.30 (1), p.56-65

2019

Volltextzugriff (PDF)

Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months

Research and practice in thrombosis and haemostasis, 2022-03, Vol.6 (3), p.e12707-n/a, Article e12707

2022

Volltextzugriff (PDF)

Microsatellite markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak syndrome: identification of the second HPS7 mutation in a patient presenting late in life

Thrombosis and haemostasis, 2013, Vol.109 (4), p.766

2013

Volltextzugriff (PDF)

Mutation in GNE is associated with severe congenital thrombocytopenia

Blood, 2018-10, Vol.132 (17), p.1855-1858

2018

Volltextzugriff (PDF)

Antiplatelet drugs block platelet activation by VITT patient serum

Blood, 2021-12, Vol.138 (25), p.2733-2740

2021

Volltextzugriff (PDF)

Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel

Blood, 2012-12, Vol.120 (25), p.5041-5049

2012

Volltextzugriff (PDF)

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects

Blood, 2013-12, Vol.122 (25), p.4090-4093

2013

Volltextzugriff (PDF)

Comprehensive functional characterization of a novel ANO6 variant in a new patient with Scott syndrome

Journal of thrombosis and haemostasis, 2024-08, Vol.22 (8), p.2281-2293

2024

Volltextzugriff (PDF)

SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects

The Journal of clinical investigation, 2015-09, Vol.125 (9), p.3600-3605

2015

Volltextzugriff (PDF)

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Journal of thrombosis and haemostasis, 2023-12, Vol.21 (12), p.3450-3462

2023

Volltextzugriff (PDF)

Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry

Blood advances, 2022-05, Vol.6 (9), p.2932-2946

2022

Volltextzugriff (PDF)

Simultaneous measurement of ATP release and LTA does not potentiate platelet aggregation to epinephrine

Thrombosis and haemostasis, 2013-07, Vol.110 (1), p.199

2013

Volltextzugriff (PDF)

What is the role of genetic testing in the investigation of patients with suspected platelet function disorders?

British journal of haematology, 2014-04, Vol.165 (2), p.193-203

2014

Volltextzugriff (PDF)

Diversity and impact of rare variants in genes encoding the platelet G protein-coupled receptors

Thrombosis and haemostasis, 2015-04, Vol.113 (4), p.826

2015

Volltextzugriff (PDF)

A HaemSTAR is born; a trainee-led, UK-wide research network in haematology

Clinical medicine (London, England), 2019-11, Vol.19 (6), p.532-533

2019

Volltextzugriff (PDF)

A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction

Thrombosis and haemostasis, 2014, Vol.111 (5), p.923

2014

Volltextzugriff (PDF)

A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia

Research and practice in thrombosis and haemostasis, 2018-10, Vol.2 (4), p.640-652

2018

Volltextzugriff (PDF)

ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated? St. Anne's College, Oxford, 6-9 th September 2016

Platelets (Edinburgh), 2016-12, Vol.27 (8), p.719-721

2016

Volltextzugriff (PDF)

ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated?: St. Anne's College, Oxford, 6-9th September 2016

Platelets, 2016-12, Vol.27 (8), p.719-721

2016

Volltextzugriff (PDF)

Kikuchi-Fujimoto disease: a rare but important differential diagnosis for lymphadenopathy

BMJ case reports, 2014-09, Vol.2014, p.bcr2014205470

2014

Volltextzugriff (PDF)

Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders

Journal of thrombosis and haemostasis, 2014-05, Vol.12 (5), p.660-665

2014

Volltextzugriff (PDF)

A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash‐Mob’ retrospective study incorporating 961 patients

British journal of haematology, 2022-01, Vol.196 (2), p.433-437

2022

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High-throughput platelet spreading analysis: a tool for the diagnosis of platelet-based bleeding disorders

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Investigation of the contribution of an underlying platelet defect in women with unexplained heavy menstrual bleeding

Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months

Microsatellite markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak syndrome: identification of the second HPS7 mutation in a patient presenting late in life

Mutation in GNE is associated with severe congenital thrombocytopenia

Antiplatelet drugs block platelet activation by VITT patient serum

Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects

Comprehensive functional characterization of a novel ANO6 variant in a new patient with Scott syndrome

SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects

Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry

Simultaneous measurement of ATP release and LTA does not potentiate platelet aggregation to epinephrine

What is the role of genetic testing in the investigation of patients with suspected platelet function disorders?

Diversity and impact of rare variants in genes encoding the platelet G protein-coupled receptors

A HaemSTAR is born; a trainee-led, UK-wide research network in haematology

A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction

A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia

ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated? St. Anne's College, Oxford, 6-9 th September 2016

ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated?: St. Anne's College, Oxford, 6-9th September 2016

Kikuchi-Fujimoto disease: a rare but important differential diagnosis for lymphadenopathy

Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders

A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash‐Mob’ retrospective study incorporating 961 patients

Suchergebnisse filtern